{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:59:01Z","timestamp":1782266341797,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bcp.2024.116435","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:46:37Z","timestamp":1721407597000},"page":"116435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-3056","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Moreno-Gordaliza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. \u00c1ngeles","family":"Gonz\u00e1lez-Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Milagros","family":"G\u00f3mez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"L\u00f3pez-Gonz\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2024.116435_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.bcp.2024.116435_b0010","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.bcp.2024.116435_b0015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1039\/c2ja30016h","article-title":"LA-ICP-MS and nHPLC-ESI-LTQ-FT-MS\/MS for the analysis of cisplatin-protein complexes separated by two dimensional gel electrophoresis in biological samples","volume":"27","author":"Moreno-Gordaliza","year":"2012","journal-title":"J. Anal. At. Spectrom"},{"issue":"4","key":"10.1016\/j.bcp.2024.116435_b0020","doi-asserted-by":"crossref","first-page":"F955","DOI":"10.1152\/ajprenal.00294.2017","article-title":"Protection of kidneys by magnesium in cisplatin chemotherapy: a fight between two metals","volume":"313","author":"Li","year":"2017","journal-title":"Am J Physiol-Renal"},{"issue":"4","key":"10.1016\/j.bcp.2024.116435_b0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ndt\/gfs499","article-title":"Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice","volume":"28","author":"van Angelen","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.bcp.2024.116435_b0030","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin Nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.bcp.2024.116435_b0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cts.12480","article-title":"Identification of OAT1\/OAT3 as Contributors to Cisplatin Toxicity","volume":"10","author":"Hu","year":"2017","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116435_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116435_b0045","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"Santos","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116435_b0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/antiox9090821","article-title":"Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency","volume":"9","author":"Jado","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.bcp.2024.116435_b0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12882-019-1399-6","article-title":"Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.bcp.2024.116435_b0060","first-page":"1","article-title":"Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity","author":"Humanes","year":"2015","journal-title":"Biomed. Res. Int. (704382)"},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0065","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/ndt\/gfh397","article-title":"Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells","volume":"19","author":"P\u00e9rez","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.bcp.2024.116435_b0070","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2012.199","article-title":"Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats","volume":"82","author":"Humanes","year":"2012","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2024.116435_b0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/jpet.110.165779","article-title":"Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage","volume":"334","author":"Camano","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0080","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfx005","article-title":"Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection","volume":"32","author":"Humanes","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bcp.2024.116435_b0085","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.apsb.2019.02.005","article-title":"Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)","volume":"9","author":"Huo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.bcp.2024.116435_b0090","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2016060606","article-title":"Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity","volume":"28","author":"Hori","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116435_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031239","article-title":"Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy","volume":"22","author":"Zaballos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116435_b0100","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.ki.5000433","article-title":"Metabolomic study of cisplatin-induced nephrotoxicity","volume":"69","author":"Portilla","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116435_b0105","article-title":"Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients","author":"Lim","year":"2023","journal-title":"Brit J. Clin. Pharm."},{"key":"10.1016\/j.bcp.2024.116435_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114299","article-title":"Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF\/MS-based untargeted metabolomics study","volume":"183","author":"Song","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116435_b0115","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192940","article-title":"Metabolomics study of fasudil on cisplatin-induced kidney injury","volume":"39","author":"Xia","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2024.116435_b0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpba.2016.12.010","article-title":"Urinary metabolic profiling of cisplatin nephrotoxicity and nephroprotective effects of Orthosiphon stamineus leaves elucidated by 1H NMR spectroscopy","volume":"135","author":"Pariyani","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.bcp.2024.116435_b0125","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41598-017-03249-z","article-title":"Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116435_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114787","article-title":"Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury","volume":"163","author":"Lim","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2024.116435_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1039\/C5MB00492F","article-title":"Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury","volume":"12","author":"Won","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"22","key":"10.1016\/j.bcp.2024.116435_b0140","doi-asserted-by":"crossref","first-page":"12521","DOI":"10.3390\/ijms222212521","article-title":"Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by Cilastatin","volume":"22","author":"Moreno-Gordaliza","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2024.116435_b0145","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1194\/jlr.M080465","article-title":"Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity","volume":"59","author":"Moreno-Gordaliza","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116435_b0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.talanta.2016.11.026","article-title":"MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy","volume":"164","author":"Moreno-Gordaliza","year":"2017","journal-title":"Talanta"},{"issue":"14","key":"10.1016\/j.bcp.2024.116435_b0155","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s00216-013-6882-5","article-title":"Method development and validation for rat serum fingerprinting with CE\u2013MS: application to ventilator-induced-lung-injury study","volume":"405","author":"Naz","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"19","key":"10.1016\/j.bcp.2024.116435_b0160","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/elps.201300062","article-title":"Plasma and urine metabolic fingerprinting of type 1 diabetic children","volume":"34","author":"Balderas","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bcp.2024.116435_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461758","article-title":"Enhancing confidence of metabolite annotation in Capillary Electrophoresis-Mass Spectrometry untargeted metabolomics with relative migration time and in-source fragmentation","volume":"1635","author":"Mamani-Huanca","year":"2021","journal-title":"J. Chromatogr. A"},{"issue":"3","key":"10.1016\/j.bcp.2024.116435_b0170","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11306-014-0712-4","article-title":"Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample","volume":"11","author":"Godzien","year":"2015","journal-title":"Metabolomics"},{"issue":"24","key":"10.1016\/j.bcp.2024.116435_b0175","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1002\/elps.201500352","article-title":"Missing value imputation strategies for metabolomics data","volume":"36","author":"Armitage","year":"2015","journal-title":"Electrophoresis"},{"issue":"9","key":"10.1016\/j.bcp.2024.116435_b0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/metabo10090376","article-title":"Towards Standardization of Data Normalization Strategies to Improve Urinary Metabolomics Studies by GC\u00d7GC-TOFMS","volume":"10","author":"Nam","year":"2020","journal-title":"Metabolites"},{"issue":"W1","key":"10.1016\/j.bcp.2024.116435_b0185","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116435_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2018.02.046","article-title":"Knowledge-based metabolite annotation tool: CEU Mass Mediator","volume":"154","author":"Gil de la Fuente","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"D1","key":"10.1016\/j.bcp.2024.116435_b0195","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the Human Metabolome Database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.bcp.2024.116435_b0200","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.3390\/jcm10173991","article-title":"Targeting Mitochondria and Metabolism in Acute Kidney Injury","volume":"10","author":"Li","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116435_b0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ki.1984.143","article-title":"Enzyme distribution along the nephron","volume":"26","author":"Guder","year":"1984","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0215","first-page":"2422","article-title":"Carnitine transport and fatty acid oxidation, Biochimica et Biophysica Acta (BBA) - Molecular","volume":"1863","author":"Longo","year":"2016","journal-title":"Cell Res."},{"issue":"19","key":"10.1016\/j.bcp.2024.116435_b0220","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/1078-0432.CCR-10-1239","article-title":"Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting","volume":"16","author":"Lancaster","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116435_b0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbrc.2017.04.026","article-title":"Increased urine acylcarnitines in diabetic ApoE-\/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia","volume":"487","author":"Mirzoyan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0230","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.2009.330","article-title":"Transgenic expression of proximal tubule peroxisome proliferator\u2013activated receptor-\u03b1 in mice confers protection during acute kidney injury","volume":"76","author":"Li","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116435_b0235","first-page":"1","article-title":"Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients","author":"Lim","year":"2023","journal-title":"Brit J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2024.116435_b0240","series-title":"Amino Acids in Nutrition and Health: Amino Acids in Systems Function and Health","first-page":"71","article-title":"Amino Acid Metabolism in the Kidneys: Nutritional and Physiological Significance","author":"Li","year":"2020"},{"issue":"2","key":"10.1016\/j.bcp.2024.116435_b0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ajcn\/79.2.185","article-title":"Renal metabolism of amino acids: its role in interorgan amino acid exchange123","volume":"79","author":"van de Poll","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2024.116435_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152366","article-title":"Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF\/MS-based non-targeted urine and kidney metabolomics approach in rats","volume":"431","author":"Qu","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2024.116435_b0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fchem.2014.00061","article-title":"Membrane transporters for the special amino acid glutamine: structure\/function relationships and relevance to human health","volume":"2","author":"Pochini","year":"2014","journal-title":"Front. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116435_b0260","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.1999.277.4.F487","article-title":"Glutamate transporters in kidney and brain","volume":"277","author":"Hediger","year":"1999","journal-title":"Am. J. Physiol.-Renal"},{"issue":"3","key":"10.1016\/j.bcp.2024.116435_b0265","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1152\/ajpendo.00207.2020","article-title":"Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: an early marker of cardiometabolic disease","volume":"319","author":"Wali","year":"2020","journal-title":"Am. J. Physiol.-Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0270","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jat.2933","article-title":"Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats","volume":"34","author":"Uehara","year":"2014","journal-title":"J. Appl. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116435_b0275","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/nu11051044","article-title":"Creatine is a Conditionally Essential Nutrient in Chronic Kidney Disease: A Hypothesis and Narrative Literature Review","volume":"11","author":"Post","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.bcp.2024.116435_b0280","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1021\/acs.jproteome.6b00583","article-title":"Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans","volume":"15","author":"Zhang","year":"2016","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.bcp.2024.116435_b0285","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2008050465","article-title":"Functional TauT Protects Against Acute Kidney Injury","volume":"20","author":"Han","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2024.116435_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD(+) in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"12","key":"10.1016\/j.bcp.2024.116435_b0295","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/ckj\/sfab173","article-title":"Nicotinamide and acute kidney injury","volume":"14","author":"Fontecha-Barriuso","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.bcp.2024.116435_b0300","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1523-1755.63.s84.36.x","article-title":"N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?","volume":"63","author":"Rutkowski","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116435_b0305","doi-asserted-by":"crossref","first-page":"8603164","DOI":"10.1155\/2016\/8603164","article-title":"Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis","volume":"2016","author":"Kushiyama","year":"2016","journal-title":"Mediators Inflamm."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T22:12:27Z","timestamp":1728425547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":61,"alternative-id":["S0006295224004180"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116435","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116435"}}